In our study, we evaluated the nuclear and cytoplasmic immunohistochemical expression of CD25 and the phosphorylated form of NFkB in thyroid carcinoma, thyroid adenoma, and HT. This evidence concerns the gene NFKB1 and thyroid gland carcinoma.